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ABSTRACT:
The exocrine pancreas’ function is to synthesize and secrete a battery of enzymes in response
to secretagogues. Nitric oxide (NO) is a biological messenger in a variety of tissue types,
eliciting an impressive variety of biological responses. Biosynthesis of NO in the pancreas is
catalyzed by two known nitric oxide synthase isoforms, NOS(I) and NOS(II). However, the role
of NO in secretion from pancreatic acinar cells has been unclear. The aim of this study was to
determine the effects of nitric oxide on pancreatic secretion as well as its effects on enzymes
specific to the ERK signaling cascade, which leads to synthesis of additional secretory vesicles.
NO was shown to significantly promote pancreatic secretion most likely through a cGMP
mechanism. In addition, NO was shown to promote phosphorylation of PI3K and ERK, hence
synthesis of proteins necessary for continued secretory response, via a Shc-independent
mechanism.
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Introduction

The organs of the human body function in concert to achieve a desired
physiological effect. The pancreas is unique in that it functions as both an
endocrine and exocrine organ. Most of the pancreas is retroperitoneal and lies
deep to the greater curvature of the stomach, extending across the abdomen.
Histologically, the pancreas is divided into lobules by connective tissue septae.
Lobules are composed largely (97%) of grape-like clusters of exocrine cells
known as acini, which secrete digestive enzymes. Exocrine secretions from acini
flow successively through intercalcated ducts, intralobular ducts, interlobular
ducts and finally into the duodenum (Figure 1). Embedded within the pancreatic
exocrine tissue are Islet of Langerhans, the endocrine component that comprises
the remaining 3% of the pancreas. Five islet cell types, a-cells, p-cells, 8-cells,
pancreatic polypeptide, and C-cells are known to exist, a-cells and p-cells serve
to regulate blood glucose and insulin levels.
Chemical breakdown of food particles is initiated in the stomach where
food is converted to chyme. As chyme is slowly released into the small intestine
from the stomach, two things must happen: 1) acidic chyme must be quickly and
efficiently neutralized to prevent damage to the duodenal mucosa and, 2)
macromolecular nutrients (i.e. proteins, fats, and starch) must be further broken
down before their components can be absorbed and delivered into the circulatory
system. The function of the exocrine pancreas is to secrete acid-neutralizing
bicarbonate plus a battery of enzymes that collectively have the capacity to
W

Figure 1. A Diagrammatic Representation of the Pancreas. Exocrine cells
produce and secrete digestive enzymes into the small intestine where they
aid in the digestion of proteins, carbohydrates, lipids, DNA, and RNA.
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reduce virtually all digestible macromolecules into forms that are capable of
being absorbed. Four major groups of enzymes are critical to efficient digestion:
pancreatic lipase, amylase, nucleases, and proteases. Proteases are
synthesized as inactive proenzymes and packaged into secretory vesicles known
as zymogens. The predominant pancreatic proteases are trypsin, chymotrypsin
and carboxypeptidase. Once trypsinogen is released into the lumen of the small
intestine, it is cleaved by the intestinal mucosa-embedded enzyme enterokinase,
and thus rendered active. Once trypsin is formed, it activates chymotrypsinogen
and pro-carboxypeptidase. Trypsin and chymotrypsin digest proteins into peptide
fragments, which are ultimately digested into amino acid subunits by pancreatic
carboxypeptidase and intestinal aminopeptidase. The other macromolecules are
similarly digested with lipases cleaving fats into fatty acids, nucleases
hydrolyzing DNA and RNA into nucleotides, and amylases cleaving complex
carbohydrates into disaccharides such as maltose.
The principle stimulus to initiate pancreatic delivery of digestive enzymes
into the small intestine is cholecystokinin (CCK). CCK is a linear peptide
hormone synthesized in mucosal epithelial cells. It is released into the circulation
in response to partially digested fats and proteins in the lumen of the duodenum.
The elevation in blood concentration of CCK prompts two simultaneous actions in
pancreatic acinar cells; the exocytotic release or secretion of digestive enzymes
and the production of additional enzymes. These events lead to digestion and
absorption of the very molecules that stimulate CCK secretion. Thus, when
digestion and absorption are completed, CCK-induced secretion ceases.

CCK is the physiological signal that communicates the presence of
macromolecules in the small intestine. The pancreas must therefore possess a
sensor in the form of a plasma membrane CCK receptor that will initiate specific
signal transduction pathways leading to product synthesis or enzyme release.
The CCK receptor is a 7-transmembrane domain protein and like all other similar
proteins, links to a G-protein signal tranducer (Dabrowski et al., 1996). When the
receptor is bound to CCK, it induces the associated G-protein to release GDP
and bind GTP. Once bound to GTP, the alpha subunit of Gq dissociates from the
Py subunits. The free GTP-bound a-subunit binds and allosterically activates
PLCp. PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate into inositol 1,4,5triphosphate (IP3) and diacylglycerol (DAG). IP3 is water soluble and will bind to
IP3 receptors on the endoplasmic reticulum promoting Ca2+ release from this
intracellular store. Alternatively, DAG will activate specific PKC isoforms, which
will in turn be required for other aspects of pancreatic functioning. PKC was
originally identified as a serine/threonine kinase that was maximally active in the
presence of DAG. Five PKC isoforms (a, 8, s, 0, and Q have been identified in
pancreatic acinar cells that appear to exhibit specific patterns of lipid and calcium
dependence for activity. Recent studies indicate that increased formation of NO
is essential to activate PKC e in cardiac tissue (Ping et al., 1999). Additionally,
Kein (2000) suggests that PKCs can activate the Raf protein in the ERK signaling
pathway in pancreatic acinar cells. Therefore, it seems reasonable to suspect
that NO may promote Raf activation via PKCs stimulation in pancreatic acinar
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The CCK receptor also initiates an additional signaling pathway that leads
^

to phosphorylation of transcription factors and eventual replenishment of
secretory product. Initially, the CCK receptor activates a Src-type tyrosine
kinase. Src in turn can phosphorylate tyrosine residues on the She scaffold
protein, which appears to serve as a nucleation point in the assembly of the
signaling complex (Park et al., 1999). She phosphorylation leads to the
recruitment of adapter protein Grb2 via its SH2 domain. The SH2 domain is a
region of approximately 100 amino acids that binds to phosphotyrosines on other
proteins. The process of complexing Grb2 with She causes a conformational
exposure of Grb2’s SH3 domain. The SH3 domain binds to proline-rich regions
and provides an adapter function for subsequent protein interactions. Grb2 uses
its SH3 domain to bind and activate SOS. SOS causes GDP to be replaced by

V

GTP on Ras. Ras ia a monomeric G-protein family member activated upon
GDP/GTP exchange in response to diverse stimuli (Deora et al., 1998). Ras
activation leads to an association and allosteric activation of Raf. Raf is a
serine/threonine kinase which directly phosphorylates/activates MEK. MEK is a
dual-specificity kinase that phosphorylates and activates extracellular signalregulated kinase (ERK). Finally ERK, a ubiqitously expressed serine/threonine
protein kinase, phosphorylates transcription factors that will bind to promoters
and initiate transcription of genes important to continued secretion (Figure 2).
Previous studies utilizing rat pancreatic acini have demonstrated that CCK
strongly activates ERK as well as other upstream components of this signaling

Figure 2. A Model of the CCK Receptor Signal Transduction. Hormonal
stimulation of plasma membrane receptors initiate a phosphorylation cascade
beginning with the Src tyrosine kinase. Src phosphorylation of She initiates
formation of a complex with Grb2 and SOS. Once this complex is formed,
Ras is recruited and activated by binding to GTP. Subsequently, Ras
allosterically activates Raf, and MEK and ERK are successively
phosphorylated. ERK phosphorylates transcription factors which then
translocate to the nucleus and promote the transcription of genes (mRNA)
necessary for the synthesis of proteins required for the formation of additional
zymogen granules.

V
Transcription Factors

cascade, including the Shc-Grb2-S0S complex, MAPK kinase (MEK) and Ras
(Dabrowski et al., 1996).
In direct competition with She phosphotyrosine receptor binding,
phosphatidylinositol-3-kinase (PI3K) is also tyrosine-phosphorylated and
subsequently activates an alternate or parallel cascade (Daulhac et al., 1999).
PI3K is a cytoplasmic signaling molecule recruited to the membrane by
phosphorylation. The 85 kDa non-catalytic regulatory subunit of PI3K links the
catalytic 110 kDa subunit to activated protein receptors and is required for its
activity. p110 phosphorylates various phosphotidylinositols at the 3 position of
the inositol ring. This activity generates binding sites for proteins with pleckstrin
homology domains and additional substrates for phospholipase C (PLC).
Previous studies have revealed that some proteins involved in vesicle formation
in other tissues are regulated by the phospholipids generated by PI3K (Fukui et
al., 1998). Klippel et al. adds that PI3K activation is sufficient to activate multiple
signal-transducing kinase pathways (1996). In other systems, SOS has been
shown to possess pleckstin homology domains for activation. This observation
provides an alternative PI3K-dependent activation route for Ras and downstream
effectors. However, the distinct role of PI3K in vesicle formation and Ras
activation in pancreatic acinar cells remains to be elucidated.
A novel signaling system that is proving important in many tissues,
including the pancreas, is the nitric oxide (NO) generating system. Since its
discovery as a biological signaling molecule in 1978 (Tannenbaum et al., 1978),
nitric oxide research has become one of the most rapidly growing areas in
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molecular biology with more than 20,000 publications to date. The importance of
W

the discovery of NO is that it has revealed novel mechanisms in which signals
between cells can be generated. NO provides the first example of an
intercellular messenger for which the cell membrane poses no significant barrier
and which does not interact with a specific receptor to produce a response. NO
can function as an intracellular messenger, an auto- or paracrine molecule, a
neurotransmitter, or as a hormone that exerts its effects at multiple sites. Thus it
is a unique simple molecule sanctioning an array of signal functions.
Consisting simply of one atom of nitrogen and one atom of oxygen, its
biosynthesis is catalyzed by three known isoforms of nitric oxide synthase,
neuronal NOS(I), inducible NOS(II), and endothelial NOS(III) (Lincoln et al.,
1997). These enzymes possess different biochemical properties and their
expression is tissue dependent. Tissue specificity and different regulatory
mechanisms suggest that NO concentrations must match specific functions in
each tissue in which it is produced. Previous studies have indicated the
presence of both NOS(I) and NOS(II) in the pancreas (Xu et al., 1997). NOS(I),
also known as nNOS, is a constitutive isoform regulated at the posttranscriptional level by calmodulin (CaM) via a Ca2+-dependent mechanism
(Michikawa et al., 1998). Intracellular Ca2+ concentrations greater than or equal
to 400 nM are required for calmodulin to bind NOS and for the enzyme to
become fully active. Therefore, at normal resting intracellular Ca2+
concentrations, NOS(I) is inactive. Additionally, activity of NOS(I) produces low
levels (pmoles) of NO for a short period of time. In contrast, NOS(II), also known
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as iNOS, is activated independently of elevated intracellular Ca2+. Because
NOS(II) inherently binds CaM, it becomes active shortly after its synthesis,
regardless of intracellular Ca2+ concentration. Consequently, NOS(II) induces
relatively higher amounts of NO (nmoles) for an extended period of time. This
difference is thought to be important in terms of the Ca2+-influenced regulation of
NO synthesis and its potential function.
In many instances NO mediates its effects by activating guanylyl cyclase,
a heterodimeric hemoprotein. NO appears to bind to the heme moiety in the
guanylyl cyclase prosthetic group and induces a conformational change in the
enzyme (Schmidt et al., 1993). This results in the activation of the catalytic site
and the synthesis of cyclic GMP (cGMP) from GTP (Zhao et al., 1999). Several
studies have established cGMP as a mediator of intracellular Ca2+concentration.
Murthy and Makhlouf suggest that cGMP stimulates Ca2+ release from an IP3insensitive store (1998). Yoshida et al. reports that exogenous NO is capable of
increasing endogenous cGMP, which results in an increase in the [Ca2+]i
transient (1997). Furthermore, Xu et al. (1997) indicates that the production of
even low levels of NO, generated specifically by NOS(I) prompts the activation of
soluble guanylyl cyclase and production of cGMP. Thus, specific NOS isoforms
seem to govern distinct effects on multiple pathways within the same cell.
NO appears to be widely distributed and exerts it effects on multiple
systems throughout the body as well as within the cell. Its synthesis is catalyzed
by two distinct isoforms in pancreatic acinar cells, NOS(I), which is dependent on
Ca2+ concentration and NOS(II), which is not. Also, NO appears to both regulate

12

and be regulated by intracellular Ca2+ concentration through activation of cGMP
W

via soluble guanylyl cyclase. Although we have begun to understand the
intracellular signaling pathways activated by nitric oxide in other tissues, such
information is not yet available in pancreatic acinar cells. It seems reasonable to
ask if NO functions as an upstream signaling molecule in the ERK pathway in
pancreatic acinar cells. Furthermore, acinar cell secretion is intimately coupled
to Ca2+ and therefore begs the question: Is nitric oxide involved in the signaling
cascades leading to acinar cell secretion? The purpose of this investigation was
to further elucidate the role NO plays in both pancreatic acinar cell secretion and
synthesis of additional secretory vesicles via the ERK signaling pathway.

w
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Materials and Methods
W
Isolation of Pancreatic Acini
Male Sprague-Dawley rats (125-190g) served as the source of pancreatic
tissue. The rats were euthanized by light ether anaesthesia and subsequent
cervical dislocation, a procedure approved by the NIL) IACUC committee. The
pancreas was immediately dissected from the rat, minced thoroughly, and
transferred to a 50ml culture tube containing 20ml Hank’s growth media (Medium
199) and trypsin protease inhibitor (0.1 mg/ml). The tissue was then incubated in
a shaking water bath at 37°C for ten minutes. The cell suspension was allowed
to settle and the supernatant was removed. The pancreatic cells were washed
and resuspended in an additional 20ml of growth medium prior to experimental
treatment.

Chemicals
Reagents, antibodies, agonists and inhibitors used during this project were
purchased from various biochemical companies in the United States. Pancreatic
acinar cells were incubated in Medium 199 (Gibco BRL, Inc., Grand Island, NY),
which contained essential electrolytes and amino acids. The incubation solution
was supplemented with a variety of protease inhibitors including phenyl methyl
sulfonyl fluoride (PMSF), (Sigma Chemical Company, St. Louis, MO), trypsin
inhibitor (Gibco BRL, Inc.) and leupeptin. Protein A agarose beads were
purchased from Boehringer Mannheim and were used to immunoprecipitate
proteins following experimental treatments.
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Primary antibodies including polyclonal mouse anti-phosphotyrosine lgG 2b,
W

polyclonal rabbit anti-Shc IgG, polyclonal rabbit anti-ERK2 IgG, and polyclonal
rabbit anti-PI3K IgG were purchased from Santa Cruz Biotechnology, Inc.
Horseradish peroxidase labeled anti-rabbit IgG secondary antibody was also
purchased from Santa Cruz Biotechnology, Inc.
Cholecystokinin, an effective physiological agonist for pancreatic
secretion, was purchased from Sigma Chemical Company. 6-(2-hydroxy-1methyl-2-nitrosohydrazino)-N-methyl-1-hexanamine (NOC-9), is a nitric oxide
donor with a release half-life of 3 minutes and was purchased from CalbiochemNovabiochem Corporation. Inhibitors of various nitric oxide signal transduction
pathways were also purchased from Calbiochem-Novabiochem Corporation and
included N©-Nitro-L-Arginine-Methyl Ester, a broad based inhibitor of all NOS

w

isoforms and NG-Propyl-L-arginine, a highly selective inhibitor of the NOS(I)
isoform.

Treatment of Pancreatic Acini

Experimental treatment of pancreatic acinar cells was performed at 37°C
in a shaking water bath. Agonists and/or inhibitors were solubilized in
concentrated stock solutions and appropriate aliquots were diluted directly into
the cell suspension. In general, the cells were either assayed over a 30-minute
time course to determine the rate of exocytotic secretion by the pancreatic acini,
or alternatively, the cells were pelleted by centrifugation at 50g for three minutes
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at room temperature. This resulting pellet was lysed and subsequently subjected
W

to immunoprecipitation of tyrosine-phosphorylated proteins.

Immunoprecipitation.

Tyrosine phosphorylated proteins were extracted from the pancreatic
acinar lysates by standard immunopreciptiation protocols. Acinar cell fractions
were suspended and solubilized by homogenization (glass-Teflon potter) in an
immunoprecipitation buffer containing 150mM NaCI, 50mM Tris-HCI [pH 7.5], 1%
Nonidet P40, 0.5% deoxycholic acid, 2mM sodium orthovanidate, 1.4mM TPCK,
0.1 mM leupeptin, 1mg/ml SDS, and 1mg/ml 100mM PMSF. The suspension was
clarified by centrifugation at 12,000g for 10 minutes at 4°C. The recovered
W

supernatant was incubated with 10pl phosphotyrosine antibody for 1 hour prior to
the addition of 30uL of protein-A agarose. The samples were then incubated
overnight at 4°C on a rotator to maintain the agarose beads in suspension.
Proteins bound to the agarose-conjugated phosphotyrosine antibody were
collected by centrifugation at 12,000g for 30 seconds. The agarose beads
containing the bound antibody and tyrosyl phosphorylated proteins were washed
3 times in immunoprecipitation buffer for 20 minutes at 4°C. To remove
additional nonspecifically bound proteins, the beads were then washed 3 times in
high salt wash buffer (500mM NaCI, 50mM Tris-HCI [pH 7.5], 0.1% Nonidet P40)
and collected by centrifugation at 12,000g for 30 seconds. The beads were then
washed 3 more times in a low salt buffer (50mM Tris-HCL [pH 7.5], 0.1% Nonidet

w
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P40) and again collected by centrifugation at 12,000g for 30 seconds. Finally,
the protein-antibody complexes were dissociated from each other as well as the
agarose beads by heating (95°C) in Laemmli reducing buffer (65.2mM Tris-HCI
[pH 6.8], 25% glycerol, 2% SDS, 0.01% bromophenol blue, and 710mM (3mercaptoethanol) and heated for 5 minutes at 95°C. The suspension was then
centrifuged at 12,000g for 30 seconds, and the supernatant (containing all
tyrosine phosphorylated proteins) was removed and aliquoted into 20pl samples
and immediately frozen at -80°C.

Electrophoresis and Electroblotting

Frozen samples previously solubilized in laemmli reducing buffer were
V

heated for 8 minutes at 95°C. After cooling, equal amounts of protein from each
sample were loaded on a discontinuous SDS-polyacrylamide gel (gel
composition of 4% acrylamide/bis-acrylamide in the stacking gel and 12%
acrylamide/bis-acrylamide in the separating gel). The samples were
electrophoresed at 100V for 60-75 minutes or until the bromophenol blue dye
front reached approximately 1 to 2mm from the bottom of the gel. After
electrophoresis, gels and nitrocellulose sheets were equilibrated for 15 minutes
in transfer electrode buffer (192mM glycine, 20mM Tris, 20% methanol) to
remove extraneous salts and detergents from the gel and to uniformly wet the
nitrocellulose. Proteins were then electroblotted onto pure nitrocellulose

membrane for 1 hour at 100 volts at 4°C. The electroblot was performed with the
Mini-Trans electroblotting apparatus (Bio-Rad Laboratories).

Western Blotting and Enhanced Chemiluminescence (ECL)

Following electroblotting, unoccupied reactive sites on the nitrocellulose
sheet were blocked by rocking with 10% nonfat dry milk in TTBS (250mM NaCI,
20mM Tris [pH 7.6], 0.05% Tween-20) for 1.5 hours at room temperature.
Subsequent to blocking, nitrocellulose blots were washed 6 times with a TTBS
solution on a rocker at room temperature for 5 minutes. After washing,
nitrocellulose blots were incubated on a rocker overnight at 4°C in a solution
containing 1% non-fat dry milk in TTBS and a 1:1000 dilution of either stock
polyclonal rabbit anti- She, ERK2, or PI3K antibody. The blots were then washed
6 times for 5 minutes each in TTBS on a rocker at room temperature.
Primary antibody binding to proteins was detected using a 1:2000 dilution
of stock horseradish peroxidase labeled anti-rabbit IgG. The blot was incubated
with the secondary antibody in 1% non-fat dry milk in TTBS for 1 hour on a
rocker at room temperature. Following the incubation with the secondary
antibody, the blots were washed 6 times for 5 minutes each in TTBS on the
rocker at room temperature. After the final wash, the blots were immediately
incubated in luminol developer solution (equal volumes of cyclic diacylhydrazide
luminol and alkaline enhancer). This method relied upon the ability of bound
horseradish peroxidase to oxidize the luminol and thereby excite the cyclic
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diacylhydrazide to a higher energy state. Once excited, the activated compound
w /

decays to a lower energy state and in the process emits a photon of light
(wavelength max = 428nm). This chemiluminescence was detected using blue
light-sensitive autoradiographic ECL Hyperfilm in a darkroom setting. This
exposure was performed in a standard film-holding cassette for 15 seconds to 10
minutes, depending on the antibody and the amount of starting sample. The
exposed Hyperfilm was then developed and fixed in an automated film
developer.

Protein Assay

Protein assays were performed using the Bio-Rad Bradford Protein Assay
Kit with bovine serum albumin as a standard. Fractions were incubated in 4ml of
a 1:4 dilution of protein dye stock solution for 15 minutes at room temperature.
Individual absorbencies were read with a Beckman DU-60 spectrophotometer at
a wavelength of 595nm.

Amylase Assay

Amylase assays were performed by a modified version of Bernfeld (1955),
to determine the extent of secretion from the pancreatic acini during treatment.
Maltose was used as a disaccharide standard. Samples (25 jliI) were incubated
with 75|nl amylase resuspension buffer (0.2% Triton X-100, 50mM Tris, 100mM

NaCI, 10mM CaCI2) and 100|xl substrate (1% amylopectin, 40mM MOPS, 60mM
NaCI) for 30 minutes in a 37°C water bath. This reaction was stopped with the
addition of 0.2ml stop-development reagent (1% 3,5-dinitrosalicyclic acid, 0.4N
NaOH, 1.06M sodium potassium tartarate). The resulting fractions were heated
for 7 minutes at 95°C. The fractions were cooled and diluted with 2.6ml water.
Individual absorbencies were read with a Beckman DU-60 spectrophotometer at
a wavelength of 530nm. Amylase release was then plotted as a function of time.

Image Scanning and Quantification

Following western blotting and enhanced chemiluminescense, protein
bands on the ECL film were acquired using the computer program Adobe
Photoshop 5.0. These scanned protein bands were then quantified using the
computer program NIH Image 1.61.
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Results
W
CCK is the definitive stimulus for release of preformed secretory vesicles
containing pancreatic enzymes (Yoshida et al., 1997). This assertion was
verified experimentally when isolated cells were treated with 20nM CCK.
Figure 3 shows that CCK caused a pronounced and sustained increase in the
rate of amylase release over the course of a 30-minute period when compared to
a control from the same tissue preparation. On average, CCK caused 30% of
total amylase to be released over 30 minutes, whereas unstimulated cells
released only 8% over the same time course. Activation of pancreatic acinar
cells is thought to promote NO synthesis and two isoforms have been shown to
be expressed (Xu et al., 1997). To determine the effect of nitric oxide on
amylase release, pancreatic acinar cells were treated with 1 mM NOC-9, a nitric
oxide donor. Figure 4 shows that NOC-9 alone strongly stimulates amylase
release, comparable in magnitude to that of CCK-induced stimulation. This result
suggests that nitric oxide generation by NOC-9 is sufficient to promote a full
secretory response, independent of plasma membrane receptor activation. To
elucidate whether endogenous NO production contributes to the CCK response
and whether the NOS isoforms exhibited differential effects on amylase
secretion, isolated cells were treated with NOS inhibitors prior to incubation with
20nM CCK. The responses were then compared to cells from the same
preparation treated with CCK alone. Figure 5 illustrates that when NO synthesis
is inhibited, the secretory response to CCK stimulated secretion is blunted.
W

Figure 3. The Effect of CCK Treatment on Pancreatic Secretion (Amylase
Release). Control (♦) represents the percent of total amylase secretion over
a 30-minute time period from untreated cells. CCK (0) represents the percent
of total amylase secretion over a 30-minute time period from CCK (20nM)
treated cells. Cells were suspended in Medium 199 at 37°C and samples
were drawn from the suspension solution at the indicated time points.
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Figure 4. The Effect of NOC-9 on Pancreatic Amylase Secretion. Control (♦)
represents the percent of total amylase secretion over a 30-minute time
period from untreated cells. NOC-9 (□) represents the percent of total
amylase secretion over a 30-minute time period from NOC-9 (1 mM) treated
cells. Cells were suspended in Medium 199 at 37°C and samples were drawn
from the suspension solution at the indicated time points.
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Figure 5. CCK (•) represents the percent of total amylase secretion over a
30-minute time period from cells treated with CCK (20nM). L-NAME + CCK
(□) represents the percent of total amylase secretion over a 30-minute time
period from L-NAME (1mM) plus CCK (20nM) treated cells.
N-Propvl-aroinine (□) represents the percent of total amylase secretion over a
30-minute time period from N-Propyl-arginine (1 mM) plus CCK (20nM)
treated cells. Cells were suspended in Medium 199 at 37°C and samples
were drawn from the suspension solution at the indicated time points.
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When isolated cells were incubated with the broad-based NOS inhibitor L-NAME
W

(1 mM), subsequent stimulation with 20nM CCK was totally blocked. However,
when cells from the same preparation were treated with the specific NOS(I)
inhibitor, the CCK response was inhibited by only 50%. This result either
suggests a synergistic response between the two NOS isoforms or that NOS(II)
is preferentially important for the exocytotic branch of secretion.
CCK stimulation of pancreatic acinar cells is known to lead to activation of
intermediates in the ERK signaling pathway (Dabrowski et al., 1997). This
assertion was confirmed when cells were incubated with 20nM CCK and
immunoprecipitated for phospho-tyrosine. Figure 6 shows that cells incubated
with CCK induced a 137% ± 72 rise in She phosphorylation, when compared to a
control that received no treatment. Similarly, CCK induced a 131% ± 12 rise in

w

ERK tyrosyl-phosphorylation (Figure 7) and a 71 % ± 11 rise in PI3K tyrosylphosphorylation (Figure 8).
To determine if NO influences the ERK-associated transcription branch of
secretion, isolated pancreatic acinar cells were once again treated with 1mM
NOC-9. Following 5 minutes incubation, the cells were immunoprecipitated with
anti-phosphotyrosine antibody and probed using antibodies specific for She, ERK
or PI3K. Western blot analysis revealed that NOC-9 increases ERK2
phosphorylation by 130% ± 15 when compared to a control that received no
treatment. This level of phosphorylation was similar to that achieved using the
physiological agonist CCK. Surprisingly, NOC-9 had no effect on She
phosphorylation, which represents the proximal or initial component in the

w

Figure 6. The Effect of NOC-9 and NO Inhibitors on She Phosphorylation,
(a) CON represents the degree of phosphorylation in untreated pancreatic
acinar cells (PACs). CCK represents the degree of phosphorylation in cells
treated with CCK (20nM) for 5 minutes. LK represents the degree of
phosphorylation in cells treated with L-NAME (1mM) plus CCK (20nM) for 5
minutes, (b) CON represents the degree of phosphorylation in untreated
pancreatic acinar cells (PACs). CCK represents the degree of
phosphorylation in cells treated with CCK (20nM) for 5 minutes.
NPAK represents the degree of phosphorylation in cells treated with NPropyl-arginine (1 mM) plus CCK (20nM) for 15 minutes.

C

CON

CCK

LK

CON

CCK

<t£5j3581HI'
:
m u 1-A in |i

rsm sm k

h

(a)

*■ !

(b)

NPAK

Figure 7. The Effect of NOC-9 and NO Inhibitors on ERK Phosphorylation.
(a) CON represents the degree of phosphorylation in untreated pancreatic
acinar cells (PACs). CCK represents the degree of phosphorylation in cells
treated with CCK (20nM) for 5 minutes. NOC-9 represents the degree of
phosphorylation in cells treated with NOC-9 (1 mM) for 5 minutes. _LK
represents the degree of phosphorylation in cells pretreated with L-NAME
(1 mM) for 5 minutes prior to addition of CCK (20nM) for 5 minutes. NPAK
represents the degree of phosphorylation in cells pretreated with N-Propylarginine (1mM) for 10 minutes prior to addition of CCK (20nM) for 5 minutes
(b) NIH imaging and quantification of Western blot results show that CCK
and NOC-9 caused significant increases in the percent of tyrosyl
phosphorylation for ERK. NOS inhibitors L-NAME and N-Propyl-arginine
inhibited tyrosyl phosphorylation of ERK.
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Figure 8. The Effect of NOC-9 and NO Inhibitors on PI3K Phosphorylation.
(a) CON represents the degree of phosphorylation of in untreated pancreatic
acinar cells (PACs). CCK represents the degree of phosphorylation in cells
treated with CCK (20nM) for 5 minutes. NOC-9 represents the degree of
phosphorylation in cells treated with NOC-9 (1 mM) for 5 minutes. _LK
represents the degree of phosphorylation in cells pretreated with L-NAME
(1 mM) for 5 minutes prior to addition of CCK (20nM) for 5 minutes. NPAK
represents the degree of phosphorylation in cells pretreated with N-Propylarginine (1 mM) for 10 minutes prior to addition of CCK (20nM) for 5 minutes.
(b) NIH imaging and quantification of Western blot results show that CCK and
NOC-9 caused significant increases in the percent of tyrosyl phosphorylation
for PI3K. NOS inhibitors L-NAME caused a significant reduction of
N-Propyl-arginine inhibited tyrosyl phosphorylation of ERK.

hormone-induced cascade. This suggests that NO promotes ERK activation at a
point downstream of She. Based upon reports that NO can mediate PI3K activity
in other tissues (Pigazzi et al.t 1999) and that PI3K is an intermediate in the ERK
pathway (Conway et al., 1999), the effect of NO on PI3K activation in isolated
pancreatic acinar was also investigated. Therefore, NOC-9 treated cells were
immunoprecipitated with anti-phosphotyrosine antibody and blotted with antiPI3K. The results show that exogenous NO promoted a 71% ± 9 increase in
PI3K phosphorylation when compared to cells that received no treatment.
In order to investigate whether the specific NOS isoforms present in
pancreatic acinar cells exhibit differential effects on these same components in
the ERK pathway, cells were incubated with either L-NAME or N-Propyl-arginine
prior to stimulation with CCK. Figure 7 illustrates that when both isoforms are
inhibited by L-NAME, ERK phosphorylation is reduced by 50%. However, when
only NOS(I) is inhibited by N-Propyl-arginine, ERK phosphorylation is only
slightly reduced by 3%. Likewise, L-NAME reduced PI3K phosphorylation by
50% and N-Propyl-arginine failed to cause any significant reduction PI3K
phosphorylation (Figure 8). Consistent with previously described results
indicating that NOC-9 does not influence She phosphorylation, treatment with LNAME or N-Propyl-arginine failed to alter CCK-induced phosphorylation of She
(Figure 6).

Together these results suggest that the NOS(I) isoform exerts no

significant effect on any of the protein intermediates in the ERK signaling
cascade. NOS(II), on the other hand, seems to have a pronounced effect on
PI3K phosphorylation and a significant, although lesser, effect on ERK activation.

By implication, these results show that NO generated by NOS(II) preferentially
influences PI3K activity and downstream responses are likely due to this
proximal event.
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Discussion

Nitric oxide has now been associated with many physiological events.
Palmer et al.f first identified NO as the endothelium-derived relaxing factor
responsible for vasodilatation in cardiac tissue (1987). This discovery prompted
subsequent NO research that gave rise to the identification of three NOS
isoforms which generate NO, and characterized the differential effects generated
by endogenous NO (Michel and Lamas, 1992). In 1993, Chen and Scholfield
reported that NO modulates Ca2+ channels in neurons and Salter, Knowles and
Moncada (1993) reported that an inducible form of NOS produced excess NO in
response to lipopolysaccharide (LPS), which induces immune response. These
disparate events are likely activated by similar NO-dependent mechanisms, as is
the case for most second messengers.
Until recently, the only clearly defined NO-dependent mechanism was the
activation of guanylyl cyclase. NO binds to the heme moiety of guanylyl cyclase
to form a non-activated intermediate. Subsequent release of the heme ligand
activates the enzyme (Zhao 1999). Activated guanylyl cyclase then triggers the
formation of cGMP from GTP. The NO/cGMP system promotes Ca2+ influx by
activating ionically-gated channels in the plasma membrane, and thus provides a
mechanism for capacitative Ca2+ entry into the cell. The activation of Ca2+ influx
is required for regulating cytosolic Ca2+ concentration, for refilling internal Ca2+
stores and for activating the exocytotic branch in pancreatic acinar cells (Muallem
1989). Pandol et al., suggested that cGMP is sufficient to activate Ca2+ entry

and may mediate the effect of agonists on Ca2+ in acinar cells (1990). Because
increased cytosolic Ca2+ concentration induces exocytosis of preformed vesicles
and NO has been suggested to influence cGMP to regulate Ca2+ influx, the
current experiments were performed to demonstrate a correlation between NO
and amylase release from pancreatic acinar cells. The results showed that the
NO donor NOC-9 alone promoted a sustained secretory response comparable in
magnitude to that of the established exocytotic agonist, CCK. Furthermore, LNAME inhibition of all NOS isoforms responsible for NO synthesis abolished
CCK-induced secretory response, while selective inhibition of only NOS(I) with NPropyl-arginine resulted in a reduced secretory response. These results suggest
that both exogenous and endogenous NO are capable of stimulating the
exocytotic branch in pancreatic acinar cells, as well as the appearance of a
synergistic response between the two pancreatic NOS isoforms.
In summary, the results of this study provide evidence to support the
assertions that NO mediates pancreatic exocytotic secretion. Since exocytosis is
directly dependent on Ca2+ (Muallem 1989), NO likely acts in this situation
through a cGMP-dependent mechanism. Either exogenous or endogenous NO
can directly activate guanylyl cyclase, which in turn catalyzes the formation of
cGMP from GTP. cGMP then promotes the appropriate Ca2+ influx which is
required for exocytotic fusion between the secretory vesicle and apical plasma
membrane.
The secretion of zymogen granules containing digestive enzymes
necessitates the synthesis of additional granules via the ERK transcription

pathway in order to maintain the long-term responsiveness characteristic of the
pancreas. As illustrated in Figure 9, hormonal stimulation of plasma membrane
receptors initiate a phosphorylation cascade beginning with the Src tyrosine
kinase. Src phosphorylation of She initiates formation of a complex with Grb2
and SOS. Once this complex is formed, Ras is recruited and activated by
binding to GTP. Subsequently, Ras allosterically Raf and MEK and ERK are
successively phosphorylated. ERK phosphorylates transcription factors which
then translocate to the nucleus and promote the transcription of genes (mRNA)
necessary for the synthesis of proteins required for the formation of additional
zymogen granules. Although an increase in cytosolic Ca2+ concentration has
been shown to promote zymogen granule exocytosis, increased cytosolic Ca2+
concentration downregulates ERK phosphorylation (Kein 2000). Therefore, an
alternate mechanism of activation of this pathway must exist. Recently, NO was
demonstrated to activate ERK in postcapillary epithelium (Parenti et al., 1998). It
seemed reasonable to postulate that NO may activate ERK in pancreatic acinar
cells in a similar manner. Experiments in the preseqj study demonstrated a
positive correlation between NO and ERK activation. Treatment of isolated
acinar cells with NOC-9 caused in a 100% increase in ERK phosphorylation
when compared to cells from the same preparation that received no treatment.
This result suggests that exogenous NO alone is an effective activator of ERK.
NOS inhibitor L-NAME inhibits endogenous NO production by all NOS enzymes.
The degree of ERK phosphorylation in cells treated with L-NAME was markedly
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Figure 9. A Model of the ERK Signaling Cascade. Hormonal stimulation of
plasma membrane receptors initiate a phosphorylation cascade beginning
with the Src tyrosine kinase. Src phosphorylation of She initiates formation of
a complex with Grb2 and SOS. Once this complex is formed, Ras is recruited
and activated by binding to GTP. Subsequently, Ras allosterically activates
Raf, and MEK and ERK are successively phosphorylated. ERK
phosphorylates transcription factors which then translocate to the nucleus and
promote the transcription of genes (mRNA) necessary for the synthesis of
proteins required for the formation of additional zymogen granules.

(

<C

(

reduced by 64%. Therefore, endogenous production of NO strongly mediates
ERK phosphorylation as well.
Once NO was established to promote ERK phosphorylation, upstream
components in the ERK cascade were investigated to determine possible sites of
NO interaction. She is a scaffolding protein that serves as a recruitment site for
other signaling proteins following tyrosyl-phosphorylation. She then serves as an
initiation site for receptor-mediated phosphorylation and promotes activation of
downstream proteins. NOC-9 did not significantly affect She phosphorylation.
Treatment of acinar cells with NOS inhibitors similarly had no significant effect on
She phosphorylation. These results suggest the NO promotes ERK activation via
a Shc-independent mechanism and most likely interacts with components distal
to She in the ERK signaling cascade. Components downstream of She and
upstream of ERK include Ras, Raf and MEK. Recent studies have shown that
NO is capable of directly interacting with Ras (Lander et al., 1995). NO catalyzes
the formation of a nitrosothio group on Ras in a region that normally interacts
with guanine nucleotide exchange factors (GEF). This interaction causes a
conformational change in the protein structure of Ras. This event leads to the
exchange of GDP for GTP, thereby energizing the Ras protein (Lander et al,
1995). Activation of Ras through this mechanism may be sufficient to promote all
downstream events, including ERK phosphorylation.
Subsequent studies have also provided evidence to suggest that upon
Ras activation by NO, the catalytic p110 subunit of PI3K is recruited to the
activated portion of the Ras effector domain (Deora et al., 1998). It is thought

that by directly associating with Ras-GTP, PI3K becomes phosphorylated and
activated. The phosphorylated lipid products of PI3K activity have various
downstream targets including PKC and mitogen-activated protein kinase, ERK
(Deora et al., 1998). Therefore, NO-activated Ras should promote both PI3K
phosphorylation and ERK phosphorylation. The results of this investigation
agree with this assertion, as the data showed that NOC-9 promoted PI3K
phosphorylation and L-NAME decreased phosphorylation.
Previous work has also demonstrated that the PI3K-catalyzed production
of phosphatidylinositol 3,4,5-trisphosphate (Ptd(3,4,5)P3), drives the allosteric
activation of some PKC isoforms (Derman et al., 1997). In particular, recent
studies suggest that the PKCs isoform in certain cell lines is activated through
redundant and independent signaling pathways that require PI3K (Moriya et al.,
1996). In pancreatic acinar cells, PKCs has been suggested to activate Raf, a
pivotal member of the ERK signaling cascade (Kein 2000). Other studies
suggest that full Raf activity relies on both Ras and PKC. The cumulative data in
these studies therefore suggest a parallel route in which PI3K contributes to
ERK activation via PKCs. The data in the present study reveals that NO is potent
stimulus of PI3K. Together these data provide evidence to suggest that NO
activates ERK downstream of She and likely involves direct Ras activation which
in turn promotes PI3K activation. These two signaling proteins act synergistically
to activate Raf and all subsequent downstream events.
In conclusion, based upon the results of this study and in conjunction with
previous findings, the following model is proposed (Figure 10).

Figure 10. A Model for the Interaction of NO with the ERK Signaling
Cascade. Cholecystokinin binds to its receptor on the acinar cell plasma
membrane and simultaneously initiates secretion as well as activation of the
ERK cascade. NO catalyzes the formation of cGMP, which results in a
sustained Ca2+ influx and initial enzyme secretion. NO also directly interacts
with Ras, which in turn activates PI3K. The lipid products of PI3K activate
PKCe. PKCs and Ras are required for activation of Raf and all downstream
components of the ERK cascade.

Cholecystokinin binds to its receptor on the acinar cell plasma membrane and
initiates two simultaneous actions: secretion of preformed zymogen granules
containing digestive enzymes commences and the synthesis of additional
product necessary for a sustained secretory. NOS(I) is activated by release of
calcium from internal stores following receptor activation of PLC and IP3
production. NO catalyzes the formation of cGMP, which results in a sustained
Ca2+ influx and initial enzyme secretion. During this process, CCK-receptor
activation also initiates the ERK cascade. Src binds the activated receptor,
phosphorylates She, which in turn forms a complex with Grb2 and SOS. This
complex induces Ras to release GDP and bind GTP. Successive components in
the cascade, Raf, MEK and ERK are subsequently phosphorylated. ERK, the
terminal enzyme in the cascade then initiates the synthesis of transcription
factors necessary for the formation of NOS(II). Newly synthesized NOS(II)
generates relatively large quantities of NO. NO will maintain Ras activity and in
turn PI3K activity. Being a readily diffusable signal, NO can also amplify the
overall tissue response by diffusing into adjacent cells and promoting Ras and
PI3K activation in a paracrine manner as well. The products of the PI3Kcatalyzed reaction, phosphatidylinositol 3,4,5-trisphosphate (Ptd(3,4,5)P3), will
drive the allosteric activation of PKCe. PKCs and Ras are required for activation
of Raf, which ultimately leads to the activation of ERK. Finally, ERK
phosphorylates transcription factors necessary for mRNA production and the
manufacture of additional secretory product and proteins involved in the
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secretory response. Secretion is sustained in this manner until the initial stimulus
W 1

has abated.
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